Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Gynaecological Cancers Congress 2024

Tailoring first-line therapy in endometrial cancer (EC) according to the molecular classification

Patients with p53mut EC

Date

20 Jun 2024

Session

Tailoring first-line therapy in endometrial cancer (EC) according to the molecular classification

Topics

Tumour Site

Endometrial Cancer

Presenters

Stephanie Lheureux

Authors

S. Lheureux

Author affiliations

  • University Health Network - Princess Margaret Cancer Center, Toronto/CA

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Patients with dMMR and POLE mutation EC

Presenter: Ana Oaknin

Session: Tailoring first-line therapy in endometrial cancer (EC) according to the molecular classification

Resources:

Slides

Webcast

Patients with NSMP EC

Presenter: Mansoor Raza Mirza

Session: Tailoring first-line therapy in endometrial cancer (EC) according to the molecular classification

Resources:

Slides

Webcast

Q&A and discussion

Session: Tailoring first-line therapy in endometrial cancer (EC) according to the molecular classification

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.